These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 28299777)
1. Recurrent vulvovaginal candidiasis: A review of guideline recommendations. Matheson A; Mazza D Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):139-145. PubMed ID: 28299777 [TBL] [Abstract][Full Text] [Related]
2. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. van Schalkwyk J; Yudin MH; J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874 [TBL] [Abstract][Full Text] [Related]
3. Recurrent vulvovaginal candidiasis - current management. Watson C; Pirotta M Aust Fam Physician; 2011 Mar; 40(3):149-51. PubMed ID: 21597520 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive review of conventional and non-conventional methods of management of recurrent vulvovaginal candidiasis. Watson C; Calabretto H Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):262-72. PubMed ID: 17627679 [TBL] [Abstract][Full Text] [Related]
5. Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection. Ray A; Ray S; George AT; Swaminathan N Cochrane Database Syst Rev; 2011 Aug; (8):CD008739. PubMed ID: 21833970 [TBL] [Abstract][Full Text] [Related]
6. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.]. Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489 [TBL] [Abstract][Full Text] [Related]
7. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. Sobel JD; Wiesenfeld HC; Martens M; Danna P; Hooton TM; Rompalo A; Sperling M; Livengood C; Horowitz B; Von Thron J; Edwards L; Panzer H; Chu TC N Engl J Med; 2004 Aug; 351(9):876-83. PubMed ID: 15329425 [TBL] [Abstract][Full Text] [Related]
12. Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines. Nyirjesy P; Brookhart C; Lazenby G; Schwebke J; Sobel JD Clin Infect Dis; 2022 Apr; 74(Suppl_2):S162-S168. PubMed ID: 35416967 [TBL] [Abstract][Full Text] [Related]
13. A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis. Brand SR; Degenhardt TP; Person K; Sobel JD; Nyirjesy P; Schotzinger RJ; Tavakkol A Am J Obstet Gynecol; 2018 Jun; 218(6):624.e1-624.e9. PubMed ID: 29534874 [TBL] [Abstract][Full Text] [Related]
14. Management of chronic vulvovaginal candidiasis: a long term retrospective study. Nguyen Y; Lee A; Fischer G Australas J Dermatol; 2017 Nov; 58(4):e188-e192. PubMed ID: 27250078 [TBL] [Abstract][Full Text] [Related]
16. Possible misdiagnosis, inappropriate empiric treatment, and opportunities for increased diagnostic testing for patients with vulvovaginal candidiasis-United States, 2018. Benedict K; Lyman M; Jackson BR PLoS One; 2022; 17(4):e0267866. PubMed ID: 35482794 [TBL] [Abstract][Full Text] [Related]
17. The development of evidence-based guidelines for over-the-counter treatment of vulvovaginal candidiasis. Bond CM; Watson MC; Pharm World Sci; 2003 Aug; 25(4):177-81. PubMed ID: 12964498 [TBL] [Abstract][Full Text] [Related]